항암화학요법을 시행받은 부인암 환자에서 recombinant human erythropoietin의 임상적 유용성

키워드

참고문헌 (35)

1. Abels RI, "Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer", 19(38), pp.29~35 (1992)
2. Johnston E, "The haematologic support of the cancer patients", pp.549~569 (1998), Lippincott-Raven Publishers
3. Abels RI, "Recombinant human erythropoietin in the treatment of anaemia of cancer", 87(1), pp.4~11 (1992)
4. Hasegawa I, "Serum erythropoietin levels in gynecologic cancer patients during cisplatin combinant chemotherapy", 46, pp.65~8 (1992)
5. Henry DH, "Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia results of double-blind and open-label follow-up studies", pp.2 21~3 8
6. Wood PA, "Cisplatin-associated anemia:an erythropoietin deficiency syndrome", 95, pp.1650~1659 (1995)
7. Miller CB, "Decreased erythropoietin response in patients with the anemia of cancer", 322, pp.1689~1692 (1990)
8. Falkson CI, "Recombinant human erythropoietin in the treatment of cancer-related anaemia", 51, pp.497~501 (1994)
9. Fedeli A, "Recombinant human erythropoietin treatment in cisplatin-associated anemia double-blind trial with placebo", pp.1058~62
10. Ludwig H, "Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors", pp.161~7
11. Ludwig H, "Schuster J Prediction of response to erythropoietin treatment in chronic anemia of cancer", 84, pp.1056~63 (1994)
12. Markman M, "The use of recombinant human erythropoietin to prevent carboplatin-induced anemia", 49, pp.172~6 (1993)
13. Means RT Jr, "Progress in understanding the pathogenesis of the anemia of chronic disease", 80, pp.1639~47 (1992)
14. Skillings JR, "The frequency of red cell transfusion for anemia in patients receiving chemotherapy:a retrospective cohort study", 16, pp.22~5 (1993)
15. Beguin Y, "Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen", 82, pp.2010~6 (1993)
16. Leitgeb C, "Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin", 73(10), pp.2535~42 (1994)
17. Schipper H, "Measuring the quality of life of cancer patients", pp.472~83, Clinch J
18. Gill TM, "A critical appraisal of the quality of quality- of-life measurements", 272, pp.619~26 (1994)
19. Priestman TJ, "Evaluation of quality of life in patients receiving treatment for advanced breast cancer", 24, pp.899~900 (1976)
20. Durie BG, "A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features response to treatment", pp.842~54
21. Manegold C, "The causes and prognostic significance of low hemoglobin levels in tumour patients", 174(4), pp.17~19 (1998)
22. Kasper C, "Pathophysiology of cancer-related anaemia RhErythropoietin in Cancer Supportive Treatment", pp.13~34 (1996), Marcel Dekker Inc 1996
23. Alexopoulos CG, "Adverse effect of cis- diamminedichloroplatinum II on porphyrin metabolism in man", pp.165~70
24. Platanias LC, "Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients", 9, pp.2021~6 (1991)
25. Matsumoto T, "Effect of recombinant human erythropoietin in anticancer drug-induced anaemia", 75, pp.463~8 (1990)
26. Miller CB, "Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia", 84, pp.98~103 (1992)
27. Henry DH, "Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients Receiving Cisplatin Chemotherapy", 1, pp.252~ (1995)
28. Fedeli A, "Cisplatin-associated anaemia treated with subcutaneous erythropoietin", pp.156~8
29. Kurz Ch, "Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies", 65, pp.461~466 (1997), double-blind placebo-controlled multicenter study
30. Eschbach JW, "Recombinant human erythropoietin in anemic patients with end-stage renal disease Results of a phase III multicenter clinical trial", pp.992~1000
31. Ludwig H, "Erythropoietin treatment of anemia associated with multiple myeloma", 322, pp.1693~9 (1990)
32. Liberato NL, "Subcutanous erythropoietin for treatment of refractory anemia in hematologic disorders Results of a phase I", II clinical trial, 29~37
33. Palcic B, "Reduced oxygen enhancement ratio at low doses of ionizing radiation", 100, pp.328~39 (1984)
34. Lavey RS, "Clinical trial experience using erythropoietin during radiation therapy", 174(4), pp.24~30 (1998)
35. Jilani SM, Glaspy JA, "Impact of epoetin alfa in chemotherapy- associated anemia", 25, pp.571~576 (1998)

관련 논문AI추천